P1027: UPDATED DURABILITY OF RESPONSE AND SAFETY IN MANIFEST ARM 3: PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB FOR JAK INHIBITOR TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS

• Claire Harrison,
• Andrea Patriarca,
• Vikas Gupta,
• Francesca Palandri,
• Timothy Devos,
• Raajit K Rampal,
• Moshe Talpaz,
• Alessandro Vannucchi,
• Andrew Kuykendall,
• Jean-Jacques Kiladjian,
• Srdan Verstovsek,
• Ruben Mesa,
• Gozde Colak,
• Soumik Dutta,
• Sandra Klein,
• Jie Cui,
• Tzuu-Wang Chang,
• John Mascarenhas

Affiliations

Claire Harrison

1 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom

Andrea Patriarca

2 Hematology Unit, AOU Maggiore della Carità and University of Eastern Piedmont, Novara, Italy

Vikas Gupta

3 Princess Margaret Hospital, Medical Oncology and Hematology, Toronto, Canada

Francesca Palandri

4 Department of Hematology at the Institute of Hematology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy

Timothy Devos

5 University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), Leuven, Belgium

Raajit K Rampal

6 Memorial Sloan Kettering Cancer Center, Leukemia Service, New York, United States

Moshe Talpaz

7 University of Michigan, Michigan Medicine, Michigan, United States

Alessandro Vannucchi

8 Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy

Andrew Kuykendall

9 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Jean-Jacques Kiladjian

10 Université Paris Cité and Hopital Saint-Louis, AP-HP, Clinical Investigation Center, Paris, France

Srdan Verstovsek

11 Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, United States

Ruben Mesa

12 Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, United States

Gozde Colak

13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States

Soumik Dutta

14 MorphoSys AG, Planegg, Germany

Sandra Klein

13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States

Jie Cui

13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States

Tzuu-Wang Chang

13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States

John Mascarenhas

15 Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, New York, United States